Ultimately, AβPP-derived iAβ, accumulated to sufficient levels (the “critical threshold” referred to above), triggers activation of the operation of the AβPP-independent iAβ production pathway and thus initiates the second AD stage. The gene discussed is APP; the disease is Alzheimer disease.